Ark Therapeutics Appoints Russell Banks as CFO
Pharmaceutical firm Ark Therapeutics has appointed Russell Banks as chief financial officer (CFO). Banks has been selected for the role following the departure of predecessor David Bowyer, who has chosen to take up a new position at a company based in his native Zimbabwe.
Banks previously served as the European finance director for medical company Cephalon for more than a decade, playing a key role in the business’ growth during this period.
Comments are closed.